Stock Research Report for Global Longlife Hospital and Research Ltd
Stock score of Global Longlife Hospital and Research Ltd moved down by 1 in a month on a 10 point scale (Source: Refinitiv). Get detailed report on Global Longlife Hospital and Research Ltd by subscribing to ETPrime.
Get 4000+ Stock Reports worth₹ 1,499* with ETPrimeat no extra cost for you
*As per competitive benchmarking of annual price. T&C apply
Make Investment decisions
with proprietary stock scores on earnings, fundamentals, relative valuation, risk and price momentum
Find new Trading ideas
with weekly updated scores and analysts forecasts on key data points
In-Depth analysis
of company and its peers through independent research, ratings, and market data
Global Longlife Hospital and Research Limited is a multispecialty hospital operator providing medical and allied services. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gi medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cvts, joint replacement and ortho, general surgery, onco surgery, gi surgery, neurosurgery and ear, nose and throat. Its radiology services include mammography, ct scan, x-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
